Speaking to reporters on Sunday, Kamalvandi said 40 types of radiopharmaceuticals are currently being produced inside Iran and they have been exported to a number of countries, including European states, since early 2016.
He emphasized that the production of new and monopolized radiopharmaceuticals is high on the AEOI agenda.
The spokesman went on to say that the production of molybdenum-99 (99Mo), which is produced through fission of uranium and only few countries have the knowhow to produce it, is also on agenda.
Iranian experts in the pharmaceutical industry have in recent years made great headways in producing medicines used to cure a broad range of diseases.